Bridging solvent molecules mediate RNase A - Ligand binding.

Area of Science:

• Biochemistry and Molecular Dynamics
• Computational Chemistry
• Drug Design

Background:

• Ribonuclease A (RNase A) is a crucial enzyme in protein science and a model system in computational studies.
• RNase A is also a significant target for drug design due to its biological relevance.

Purpose of the Study:

• To investigate the role of solvent-mediated interactions in RNase A-ligand binding using molecular dynamics.
• To analyze the energetic contribution of bridging solvent molecules in the binding process.
• To develop and assess computational methods for studying these interactions.

Main Methods:

• Performed extensive molecular dynamics simulations (8.8 μs standard, 8.8 μs modified Amber parameters) of RNase A with 22 ligands.
• Analyzed short-lived, solvent-mediated bridging interactions crucial for ligand binding.
• Developed an automated pipeline for detecting and processing bridging interactions.

Main Results:

• Identified solvent bridges as critical for RNase A-ligand binding across a wide affinity range.
• Discovered a power-law relationship between solvent bridge lifetime and occurrence probability.
• Demonstrated that bridging solvent energetically functions as part of the enzyme, not the ligand.

Conclusions:

• Solvent-mediated bridging interactions are fundamental to understanding RNase A-ligand binding.
• The findings have significant implications for improving drug design strategies and computational chemistry methods.
• The developed pipeline and analysis offer a new approach to studying enzyme-ligand interactions.